Clinical Trial Update: Biomarker-Guided Allogeneic Single-Target or Dual-Target CAR-NK Cell Therapy for Advanced Solid Tumors [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update details a biomarker-guided allogeneic CAR-NK cell therapy using single-target or dual-target constructs for advanced solid tumors, cu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Colorectal Cancer
• Glioblastoma
• Melanoma
• Non-small Cell Lung Cancer
• Ovarian Cancer
• Pancreatic Ductal Adenocarcinoma
• Prostate Cancer

Drugs mentioned

• Biomarker-guided allogeneic CAR-NK cell therapy (single-target or dual-target) (CAR-NK cell therapy)

Snippet

Sponsor: Essen Biotech | Conditions: Cancer, Breast Cancer | Phase 1, Phase 2 | Status: RECRUITING